Analyst Ratings for Teva Pharma (TEVA)
TEVA Rating Summary
TEVA Price Target Summary
- Highest: $30.00 (Piper Sandler)
- Lowest: $20.00 (BofA Securities)
- Average: $25.43
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$25.43 (+49.8%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 41%
Avg. $ Target:
$25.43 (+49.8%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 41%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/6/2025 | Goldman Sachs | Matt Dellatorre | New Coverage | Buy (N/A) |
24.00 (N/A) |
17.52 (16.97) |
-3.14% | Details |
| 5/28/2025 | Truist Securities | Les Sulewski | New Coverage | Buy (N/A) |
25.00 (N/A) |
16.96 (16.97) |
0.06% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
